Allison Kemp
Physician Assistant · Parker, CONPI 1447788971
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 677 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 677 payments — averaging $17.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Antares Pharma, Inc.$1K
- Amneal Pharmaceuticals LLC$1K
- Amgen$1K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- AstraZeneca$999
- plus $5K from 33 others
What the payments were for
- Speaking & faculty fees$2182%
- Food & beverage$11,54398%
- Education$530%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Antares Pharma, Inc. | 128 | $1,482 |
| Amneal Pharmaceuticals LLC | 69 | $1,150 |
| Amgen | 64 | $1,124 |
| Lilly USA, LLC | 71 | $1,118 |
| Novo Nordisk | 80 | $1,033 |
| AstraZeneca(2 entities) | 37 | $999 |
| Cequr Corporation | 4 | $822 |
| Medtronic | 33 | $614 |
| Sanofi-aventis U.S. LLC | 28 | $499 |
| AbbVie | 21 | $395 |
| Boehringer Ingelheim | 14 | $261 |
| Halozyme Inc | 21 | $251 |
| Dexcom, Inc. | 11 | $219 |
| Radius Health, Inc. | 14 | $218 |
| Amphastar Pharmaceuticals, Inc. | 5 | $194 |
| Mannkind Corporation | 12 | $168 |
| IBSA Pharma Inc. | 8 | $162 |
| Bayer | 5 | $88 |
| BETA Bionics, Inc. | 5 | $85 |
| Novartis | 4 | $81 |
| Ascendis Pharma Endocrinology Inc | 4 | $74 |
| Kyowa Kirin, Inc. | 3 | $68 |
| Insulet Corporation | 4 | $63 |
| Recordati_rare_diseases_inc. | 3 | $60 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Ultragenyx Pharmaceutical Inc. | 3 | $56 |
| Pfizer | 3 | $56 |
| Alvogen Inc | 2 | $52 |
| Corcept Therapeutics | 2 | $44 |
| Clarus Therapeutics Inc. | 2 | $43 |
| GRT US Holding, Inc. | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Tandem Diabetes Care, Inc. | 2 | $37 |
| Acerus Pharmaceuticals Corporation | 2 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Merck | 2 | $27 |
| Sequel Med Tech, LLC | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| EUSA Pharma (US) LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$772
- FARXIGA$402
- Prolia$121
- MOUNJARO$108
How this compares
$11,813 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 116 | $165,944 |
| OzempicSemaglutide | 80 | $123,929 |
| TrulicityDulaglutide | 51 | $72,924 |
| FarxigaDapagliflozin Propanediol | 60 | $72,183 |
| JardianceEmpagliflozin | 36 | $59,260 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $13,513 |
| RybelsusSemaglutide | 11 | $9,970 |
| SynthroidLevothyroxine Sodium | 78 | $8,516 |
| HumalogInsulin Lispro | 12 | $4,280 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,151 |
| UnithroidLevothyroxine Sodium | 28 | $2,000 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 16 | $1,153 |
| Glipizide | 11 | $741 |
| Metformin Hcl ErMetformin Hcl | 55 | $624 |
| Metformin Hcl | 55 | $507 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $1,118 | $243,148179 claims |
| Novo NordiskOzempic, Rybelsus | $1,033 | $133,89991 claims |
| AstraZenecaFarxiga | $999 | $72,18360 claims |
| Boehringer IngelheimJardiance | $261 | $59,26036 claims |
| AbbVieSynthroid | $395 | $8,51678 claims |
| Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium | $1,150 | $2,25763 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.
Other physician assistant in Parker
- Karissa HoemeParker$11K
- Donald MooreEnglewood$246K
- Neekan AeiniGreenwood Village$234K
- Korby HowellCortez$182K
- Heather FinlaysonLittleton$180K
- Kristen LervikDenver$131K
- Marissa Moritz-GuzikLouisville$94K
- Clayton LabaumeDurango$87K
- Emily FrischDenver$79K
- Daniel HumerLone Tree$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.